Sonja Baumli

2.3k total citations
19 papers, 1.8k citations indexed

About

Sonja Baumli is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Sonja Baumli has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Genetics. Recurrent topics in Sonja Baumli's work include Cancer-related Molecular Pathways (9 papers), RNA modifications and cancer (6 papers) and Genomics and Chromatin Dynamics (5 papers). Sonja Baumli is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), RNA modifications and cancer (6 papers) and Genomics and Chromatin Dynamics (5 papers). Sonja Baumli collaborates with scholars based in United Kingdom, Germany and Australia. Sonja Baumli's co-authors include Patrick Cramer, Sabine Hoeppner, Jane Endicott, Tomislav Kamenski, L.N. Johnson, Anton Meinhart, Alison J. Hole, Graziano Lolli, Stefan Knapp and Luisa Rusconi and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Sonja Baumli

19 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonja Baumli United Kingdom 17 1.4k 404 182 174 121 19 1.8k
Sharlyn J. Mazur United States 26 2.3k 1.7× 849 2.1× 74 0.4× 132 0.8× 126 1.0× 48 2.8k
Simon Bergqvist United States 25 1.5k 1.1× 599 1.5× 305 1.7× 128 0.7× 233 1.9× 35 2.3k
Klaus Godl Germany 20 1.0k 0.7× 281 0.7× 94 0.5× 154 0.9× 165 1.4× 23 1.5k
Hendrik L. De Bondt Belgium 14 1.1k 0.8× 444 1.1× 80 0.4× 356 2.0× 100 0.8× 22 1.6k
Venkatasubramanian Dharmarajan United States 20 1.4k 1.0× 190 0.5× 74 0.4× 75 0.4× 79 0.7× 27 1.8k
Annette Kärcher Germany 12 2.2k 1.6× 674 1.7× 92 0.5× 195 1.1× 53 0.4× 16 2.8k
Joanna F. McGouran United Kingdom 20 2.2k 1.6× 399 1.0× 58 0.3× 86 0.5× 265 2.2× 42 2.5k
Hao Shao United States 21 909 0.7× 252 0.6× 182 1.0× 242 1.4× 162 1.3× 47 1.3k
Thomas G. Scott United States 13 1.5k 1.1× 337 0.8× 51 0.3× 64 0.4× 98 0.8× 28 1.8k
Catherine A. Musselman United States 31 2.6k 1.9× 219 0.5× 46 0.3× 78 0.4× 67 0.6× 50 2.9k

Countries citing papers authored by Sonja Baumli

Since Specialization
Citations

This map shows the geographic impact of Sonja Baumli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Baumli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Baumli more than expected).

Fields of papers citing papers by Sonja Baumli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Baumli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Baumli. The network helps show where Sonja Baumli may publish in the future.

Co-authorship network of co-authors of Sonja Baumli

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja Baumli. A scholar is included among the top collaborators of Sonja Baumli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja Baumli. Sonja Baumli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zaborowska, Justyna, Sonja Baumli, Clélia Laitem, et al.. (2014). Herpes Simplex Virus 1 (HSV-1) ICP22 Protein Directly Interacts with Cyclin-Dependent Kinase (CDK)9 to Inhibit RNA Polymerase II Transcription Elongation. PLoS ONE. 9(9). e107654–e107654. 41 indexed citations
2.
Shao, Hao, Shi‐Liang Huang, Alison J. Hole, et al.. (2013). Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities. Journal of Medicinal Chemistry. 56(3). 640–659. 104 indexed citations
3.
Baumli, Sonja, Alison J. Hole, Lan-Zhen Wang, M.E.M. Noble, & Jane Endicott. (2012). The CDK9 Tail Determines the Reaction Pathway of Positive Transcription Elongation Factor b. Structure. 20(10). 1788–1795. 27 indexed citations
4.
Kryštof, Vladimı́r, Sonja Baumli, & Robert Fürst. (2012). Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target. Current Pharmaceutical Design. 18(20). 2883–2890. 95 indexed citations
5.
Hole, Alison J., Sonja Baumli, Hao Shao, et al.. (2012). Comparative Structural and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 Inhibitors Suggest the Basis for Isotype Selectivity. Journal of Medicinal Chemistry. 56(3). 660–670. 55 indexed citations
6.
Baumli, Sonja, Alison J. Hole, M.E.M. Noble, & Jane Endicott. (2012). The CDK9 C-helix Exhibits Conformational Plasticity That May Explain the Selectivity of CAN508. ACS Chemical Biology. 7(5). 811–816. 51 indexed citations
7.
Mourão, André, Martin Seizl, Bernd Simon, et al.. (2011). Structure and VP16 binding of the Mediator Med25 activator interaction domain. Nature Structural & Molecular Biology. 18(4). 404–409. 88 indexed citations
8.
Baumli, Sonja, Jane Endicott, & L.N. Johnson. (2010). Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB. Chemistry & Biology. 17(9). 931–936. 90 indexed citations
9.
Lorenzen, Kristina, et al.. (2010). Preparation and topology of the Mediator middle module. Nucleic Acids Research. 38(10). 3186–3195. 35 indexed citations
10.
Bettayeb, Karima, Nadège Loaëc, Alison J. Hole, et al.. (2010). CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells. Genes & Cancer. 1(4). 369–380. 68 indexed citations
11.
Baumli, Sonja, et al.. (2010). The binding of flavopiridol to blood serum albumin. Chirality. 22(1E). E40–3. 9 indexed citations
12.
Baumli, Sonja, Graziano Lolli, E.D. Lowe, et al.. (2008). The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. The EMBO Journal. 27(13). 1907–1918. 286 indexed citations
13.
Cramer, Patrick, Karim‐Jean Armache, Sonja Baumli, et al.. (2008). Structure of Eukaryotic RNA Polymerases. Annual Review of Biophysics. 37(1). 337–352. 222 indexed citations
14.
Seizl, Martin, Laurent Larivière, Fabian Kurth, et al.. (2008). Identification, structure, and functional requirement of the Mediator submodule Med7N/31. The EMBO Journal. 28(1). 69–80. 47 indexed citations
15.
Johnson, L.N., Sonja Baumli, Graziano Lolli, & E.D. Lowe. (2008). Flavopiridol binding to P-TEFb (CDK9/cyclin T1). Acta Crystallographica Section A Foundations of Crystallography. 64(a1). C122–C122. 1 indexed citations
16.
Kuhn, Claus‐D., S. Geiger, Sonja Baumli, et al.. (2007). Functional Architecture of RNA Polymerase I. Cell. 131(7). 1260–1272. 169 indexed citations
17.
Hoeppner, Sabine, Sonja Baumli, & Patrick Cramer. (2005). Structure of the Mediator Subunit Cyclin C and its Implications for CDK8 Function. Journal of Molecular Biology. 350(5). 833–842. 44 indexed citations
18.
Meinhart, Anton, Tomislav Kamenski, Sabine Hoeppner, Sonja Baumli, & Patrick Cramer. (2005). A structural perspective of CTD function. Genes & Development. 19(12). 1401–1415. 265 indexed citations
19.
Baumli, Sonja, Sabine Hoeppner, & Patrick Cramer. (2005). A Conserved Mediator Hinge Revealed in the Structure of the MED7·MED21 (Med7·Srb7) Heterodimer. Journal of Biological Chemistry. 280(18). 18171–18178. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharlyn J. Mazur Breakdown of academic impact, for papers by Simon Bergqvist Breakdown of academic impact, for papers by Klaus Godl Breakdown of academic impact, for papers by Hendrik L. De Bondt Breakdown of academic impact, for papers by Venkatasubramanian Dharmarajan Breakdown of academic impact, for papers by Annette Kärcher Breakdown of academic impact, for papers by Joanna F. McGouran Breakdown of academic impact, for papers by Hao Shao Breakdown of academic impact, for papers by Thomas G. Scott Breakdown of academic impact, for papers by Catherine A. Musselman
Rankless by CCL
2026